PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | +8.0% | 450 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | -7.4% | 450 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | -18.2% | 450 | -4.3% | 0.00% | – |
| Q1 2021 | $33,000 | +17.9% | 470 | 0.0% | 0.00% | – |
| Q4 2020 | $28,000 | -3.4% | 470 | -1.5% | 0.00% | – |
| Q3 2020 | $29,000 | +20.8% | 477 | +6.0% | 0.00% | – |
| Q2 2020 | $24,000 | +60.0% | 450 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -25.0% | 450 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |